0 seconds of 35 minutes, 58 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
35:58
35:58
 

Welcome to the Trade To Black podcast on Stockhouse.com.

In this episode, Shadd Dales, Anthony Varrell and Benjamin Smith discuss a conversation with AdvisorShares Investments Managing Director Dan Ahrens and they talk in-depth about the following stories:

  • AYR has made significant changes to its debt structure, pushing it to 2026.
  • Cybin Inc. has released promising Phase 2 interim findings for CYB003 where it produced arguably the most significant breakthrough research the industry has ever experienced.
  • The DEA has proposed significant increases in production quotas for cannabis and compounds to support preclinical and clinical research.
  • A Pennsylvania House committee has held an informational meeting to explore adult-use legalization.

Go to The Dales Report for more Trade to Black podcasts and to find the latest stories making headlines around the world.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

Join the discussion: Head over to the Bullboards at Stockhouse’s stock forums and message boards to join the discussions and hear what everyone is saying about these and other stocks.


More From The Market Online
AI generated stock image

@ the Bell: Electronics tariffs pause gives room for market rally

Canada’s main stock index moved higher on Monday, aligning with a global rally after US President Donald Trump eased some of his tariffs
Artistic rendering of Miami-Dade waste-to-energy plant

AtkinsRéalis completes David Evans Enterprises majority stake acquisition

AtkinsRéalis Group (TSX:ATRL) has successfully completed its previously announced plan to acquire a 70 per cent...
NurExone Biologic Inc

A promising investment in regenerative medicine

Biopharmaceutical company NurExone (TSXV:NRX) reached a significant milestone in its efforts to revolutionize spinal cord injury treatments.
Simply Better Brands' Trubar protein bar

Simply Better Brands’ Trubar debuts in Target nationwide

Simply Better Brands (TSXV:SBBC) announces that its Trubar protein bar is now available in select Target stores across the United States.